Immunodeficiency, common variable, 10: genes and variants
Explore variant evidence for Immunodeficiency, common variable, 10 across 6 analyzed proteins (TNFRSF13B, NFKB2, TNFRSF13C, CD19, ICOS and 1 more). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 533 variants of uncertain significance and 41 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Immunodeficiency, common variable, 10
TNFRSF13B: Tumor necrosis factor receptor superfamily member 13B
It responds to BAFF and APRIL and regulates B-cell survival, antibody production, and immunoglobulin class switching. Pathogenic variants are enriched in common variable immunodeficiency and can contribute to antibody deficiency, although penetrance is incomplete for many heterozygous alleles.
2 ClinVar pathogenic / likely pathogenic and 144 uncertain variants in TNFRSF13B have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
NFKB2: Nuclear factor NF-kappa-B p100 subunit
Processing of its p100 precursor generates p52 for the noncanonical NF-kappaB pathway, which is important for lymphoid-organ development and B-cell biology. Pathogenic variants can cause common variable immunodeficiency with endocrine and autoimmune abnormalities.
1 ClinVar pathogenic / likely pathogenic and 267 uncertain variants in NFKB2 have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
TNFRSF13C: Tumor necrosis factor receptor superfamily member 13C
It provides a crucial survival signal for transitional and mature B cells in response to BAFF. Biallelic loss-of-function variants can cause antibody deficiency with markedly reduced mature B-cell numbers.
1 ClinVar pathogenic / likely pathogenic and 86 uncertain variants in TNFRSF13C have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
CD19: B-lymphocyte antigen CD19
It amplifies B-cell receptor signaling and helps set the threshold for B-cell activation throughout much of B-cell development. Loss-of-function variants can cause antibody deficiency, while its lineage-restricted surface expression makes it a major target for monoclonal antibodies and CAR-T therapy.
1 ClinVar pathogenic / likely pathogenic and 23 uncertain variants in CD19 have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
ICOS: Inducible T-cell costimulator
It provides costimulatory signals to activated T cells, particularly supporting T-follicular-helper cells, germinal-center responses, and cytokine production. Biallelic loss-of-function variants can cause common-variable-immunodeficiency-like disease with defective antibody responses.
0 ClinVar pathogenic / likely pathogenic and 38 uncertain variants in ICOS have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
NFKB1: Nuclear factor NF-kappa-B p105 subunit
It produces p105 and the p50 NF-kappaB subunit, which regulate transcriptional responses to immune receptors, cytokines, and cellular stress. Haploinsufficiency can cause common-variable-immunodeficiency-like disease with recurrent infection, autoimmunity, and variable lymphoproliferation.
0 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in NFKB1 have source records linked to Immunodeficiency, common variable, 10. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MS4A1.
ClinVar pathogenic and likely pathogenic variants linked to Immunodeficiency, common variable, 10
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NFKB2 D865G | 865 | Pathogenic / likely pathogenic (★★) | |
| TNFRSF13C A52T | 52 | Extracellular | Pathogenic / likely pathogenic (★) |
| TNFRSF13B C104Y | 104 | TNFR-Cys 2 | Pathogenic / likely pathogenic |
| CD19 W52C | 52 | Ig-like C2-type 1 | Pathogenic / likely pathogenic |
| TNFRSF13B A181E | 181 | Transmembrane | Pathogenic / likely pathogenic |
Diseases related to Immunodeficiency, common variable, 10
- Common variable immunodeficiency, also linked to CD19, ICOS, NFKB1, NFKB2 and 1 more
- Primary ciliary dyskinesia, also linked to NFKB1
- Inherited Immunodeficiency Diseases, also linked to CD19
- Multiple myeloma, also linked to TNFRSF13B
- Acute lymphoid leukemia, also linked to CD19
- Immunoglobulin A deficiency 2, also linked to TNFRSF13B
Frequently asked questions
Which genes have records linked to Immunodeficiency, common variable, 10?
This view contains 6 analyzed proteins: TNFRSF13B, NFKB2, TNFRSF13C, CD19, ICOS and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 533 variants of uncertain significance and 41 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 642 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center